What is JadeBio?
JadeBio specializes in mass spectrometry-based proteomics services, leveraging proprietary preparation methods for diverse biological sample types. Their advanced mass spectrometry platforms facilitate deep proteome coverage, enabling the detection of post-translational modifications and precise protein quantitation. The company offers a suite of services including Selective Reaction Monitoring, proteome-wide profiling, protein identification, and characterization, positioning them as a key partner for clients engaged in biomarker discovery and therapeutic research. JadeBio's expertise also extends to antibody sequencing and characterization, further solidifying their role in advancing life sciences research.
How much funding has JadeBio raised?
JadeBio has raised a total of $49K across 1 funding round:
Debt
$49K
Debt (2021): $49K with participation from PPP
Key Investors in JadeBio
PPP
Public-Private Partnership
What's next for JadeBio?
With significant Series B/C stage funding, JadeBio is poised for accelerated growth and market expansion. The recent influx of substantial expansion capital will likely be directed towards enhancing their technological capabilities, scaling operations, and broadening their service offerings to meet the increasing demand in biomarker discovery and therapeutic research. This strategic investment signals a strong trajectory for JadeBio as they continue to innovate in the complex field of proteomics, aiming to provide deeper biological insights and support the development of next-generation therapeutics.
See full JadeBio company page
